Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
Loading...
Date
2022
Authors
Vermersch, Patrick
Brieva Ruiz, Luis
Fox, Robert J.
Paul, Friedemann
Ramió Torrentà, Lluís
Schwab, Matthias
Moussy, Alain
Mansfield, Colin
Hermine, Olivier
Maciejowski, Maciej
Other authors
Impact
Export
Share
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
Neurology: Neuroimmunology & Neuroinflammation, 2022, vol. 9, núm. 3